What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Antibiotics
The scientist’s investigation covers issues in Colistin, Antibiotics, Pharmacokinetics, Microbiology and Antibacterial agent.
His Colistin study incorporates themes from Pseudomonas aeruginosa, Pharmacodynamics, Pharmacology, Polymyxin and Drug resistance.
The Antibiotics study which covers Intensive care medicine that intersects with Susceptibility testing, Treatment outcome, Cefepime and Meningitis.
His work deals with themes such as Anesthesia, Urine, Nephrotoxicity and Renal function, which intersect with Pharmacokinetics.
The study of Microbiology is intertwined with the study of Acinetobacter baumannii in a number of ways.
His Antibacterial agent research is multidisciplinary, relying on both High-performance liquid chromatography, Chromatography, Klebsiella pneumoniae and Antimicrobial pharmacodynamics.
His most cited work include:
- Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections (944 citations)
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients (527 citations)
- Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review (519 citations)
What are the main themes of his work throughout his whole career to date?
Roger L. Nation spends much of his time researching Pharmacokinetics, Colistin, Pharmacology, Microbiology and Antibiotics.
As a member of one scientific family, Roger L. Nation mostly works in the field of Pharmacokinetics, focusing on Renal function and, on occasion, Creatinine.
His Colistin study combines topics in areas such as Antibacterial agent, Nephrotoxicity, Polymyxin B, Dosing and Polymyxin.
His studies in Pharmacology integrate themes in fields like Regimen, Kidney and Toxicity.
The Microbiology study combines topics in areas such as Pseudomonas aeruginosa, Acinetobacter baumannii and Lipopolysaccharide.
His Antibiotics research incorporates elements of Combination therapy and Intensive care medicine.
He most often published in these fields:
- Pharmacokinetics (33.75%)
- Colistin (31.50%)
- Pharmacology (33.25%)
What were the highlights of his more recent work (between 2016-2021)?
- Polymyxin (22.00%)
- Polymyxin B (19.00%)
- Pharmacokinetics (33.75%)
In recent papers he was focusing on the following fields of study:
Roger L. Nation mostly deals with Polymyxin, Polymyxin B, Pharmacokinetics, Colistin and Microbiology.
His work in Polymyxin addresses issues such as Nephrotoxicity, which are connected to fields such as Acute kidney injury and Side effect.
Roger L. Nation has included themes like Urine, Klebsiella pneumoniae, MCR-1 and Dosing in his Polymyxin B study.
His Pharmacokinetics research is classified as research in Pharmacology.
His study in the field of Colistimethate is also linked to topics like In patient.
The concepts of his Microbiology study are interwoven with issues in Pseudomonas aeruginosa and Acinetobacter baumannii.
Between 2016 and 2021, his most popular works were:
- International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). (176 citations)
- Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B? (76 citations)
- Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models. (42 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Biochemistry
His primary areas of study are Colistin, Polymyxin, Microbiology, Polymyxin B and Antibiotics.
His Colistin study integrates concerns from other disciplines, such as Acute kidney injury and Pharmacokinetics, Pharmacology.
His Pharmacokinetics research incorporates themes from Anesthesia, Critically ill and Liter.
His Microbiology research includes themes of Pseudomonas aeruginosa, Acinetobacter baumannii and Gram-negative bacteria.
His study in Polymyxin B is interdisciplinary in nature, drawing from both Nephrotoxicity and Dosing.
His work carried out in the field of Antibiotic resistance brings together such families of science as Multiple drug resistance and Acinetobacter.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
